Telomerase, the enzyme which maintains the ends of linear chromosomes in eukaryotic cells, is found at low levels in somatic stem cells but while this is incapable of preventing the progressive erosion of telomeres occurring as a consequence of cell division, such cells show greater proliferative capacity than normal somatic cells hence examination of telomerase activity in such stem cells is of interest. Our aim in this work was to examine the relationship between expression of the reverse transcriptase component (mTert) of murine telomerase. We report here the insertion of a reporter cassette comprising a segment of the promoter sequence of murine Tert gene coupled to the coding sequence of green¯uorescent protein (GFP) into murine embryonic stem (ES) cells and show that this is suf®cient for mimicking the expression of mTert. We show that the expression of mTert is very closely linked to telomerase activity and that both are substantially reduced upon differentiation of ES cells into more committed lineages giving us a potential reporter system for the selection and isolation of ES cells possessing different levels of telomerase activity. q
Introduction
The ends of the eukaryotic chromosomes, the telomeres consist of the short DNA sequence (TTAGGG) organized in long tandem arrays (3±4 kb) and are widely thought to be essential to chromosome structure and stability (Greider, 1996) . Telomeric DNA cannot be replicated by conventional DNA polymerases; this function is carried out by the specialized ribonucleoprotein complex telomerase, whose RNA moiety contains a template domain for the de novo addition of deoxynucleotides to the G-rich strand and thus allows the maintenance of telomere length (Feng et al., 1995) . Functional telomerase activity is however only found in cells capable of extended replication; examples include germline and neoplastic cells. The almost total absence of telomerase activity in most somatic cells leads to a progressive shortening of their telomeres which ends only when the cell reaches its replicative senescence checkpoint (The Hay¯ick limit; reviewed by Shay, 1997; Holt et al., 1997) .
This causal relationship between telomere degradation and replicative senescence had led to the hypothesis that telomere length may act as a`mitotic clock' associated with cellular aging in vivo (Vaziri et al., 1994) .
Not all populations of normal somatic cells have strictly proscribed replication limits. Stem cells are capable of selfrenewal such that they can be maintained for extended periods. It might thus be predicted that telomerase activity might be found in these cell types. Sensitive assays for telomerase have indeed revealed telomerase activity in populations of candidate stem cells from human fetal liver and adult bone marrow (Yui et al., 1998) and murine bone marrow (Morrison et al., 1996) . However, detectable levels of activity in these cell populations were much reduced in comparison with, for example, germ cells. There are at least two reasons for this relatively low level of telomerase activity; either telomerase activity is reduced in all cells within these populations, or telomerase activity may be relatively normal, but only present within a subset of cells in this population. It is clear that populations of hematopoietic stem cells are heterogeneous in terms of cell cycle status, proliferative and self-renewal potential. Currently there is no phenotypic marker which allows easy discrimination of these cellular potentials. The intriguing possibility is that expression of telomerase activity may re¯ect this heterogeneity in stem cell populations. It might be anticipated that those cells expressing the highest level of telomerase activity would have the greatest self renewal potential, and as such represent those stem cells that would be most useful in transplantation and gene transfer protocols, including gene therapy. In order to discriminate between these two hypotheses we need to examine telomerase activity on a single cell basis. However, direct assays of telomerase (such as the TRAP assay) are only poorly able to determine activity on a single cell basis. Further, such assays cause lysis of the cell under study, which patently excludes examining stem cell potential on a single cell basis. An alternative approach could to examine molecular correlates of telomerase activity, which might be used to drive expression of reporter molecules. One approach to identifying such correlates is to correlate the expression of the molecular components of telomerase with the enzymatic activity.
Three major subunits that comprise the murine telomerase complex have been identi®ed: (i) the RNA component mTR which provides the template for telomere repeat synthesis (Blasco et al., 1995) ; (ii) the mammalian homologue of p80, TEP1/TLP1 (Harrington et al., 1997) ; and (iii) the protein subunit mTert which acts as a reverse transcriptase (Martin-Riviera et al., 1998) . In humans, TERT is the prime candidate for the regulating and/or catalytic subunit of telomerase as several investigators have shown that telomerase activity in a variety of human tumors correlates closely with the expression of the human homologue hTERT (Meyerson et al., 1997) . Most importantly, ectopic expression of hTERT is suf®cient to restore telomerase activity in human somatic cells and telomerase-negative cell lines, suggesting that in these cells the catalytic subunit is the only missing element of the telomerase holoenzyme (Bodnar et al., 1998; Nakayama et al., 1998; Counter et al., 1998; Wen et al., 1998) . Expression of TERT represents the best candidate as a correlate of telomerase expression; however, its utility is dependent upon establishing a de®nite link between TERT expression and telomerase activity in the chosen model system.
In order to do this we have taken an in vitro approach using murine embryonic stem (ES) cells. ES cells have a number of advantages. They are a normal cell type that can be maintained for extended periods in vitro, and so avoid the complications of use of immortalized cell lines. They have been shown to differentiate in vitro into somatic cell types that would allow study of telomerase expression during differentiation. In particular, all hematopoietic lineages can be derived from ES cell differentiation in vitro and as such they represent an excellent system for the study of genetic events during hematopoiesis (Nakano et al., 1994; Hole and Graham, 1997) . Further, we have de®ned a limited temporal window for the derivation of multilineage repopulating hematopoietic progenitors during this differentiation (Hole et al., 1996) and therefore have a powerful tool to study links between TERT expression, telomerase activity and ontogeny of hematopoietic stem cells. Finally, the relative ease of transgenesis in ES cells and their retained totipotency would allow future in vivo studies of telomerase activity.
In this paper we report the construction of a reporter cassette in which the expression of the gene for green¯uor-escent protein (GFP) is under the control of the promoter of murine Tert gene. We show that the expression of GFP closely mimics the changes in the expression level of mTert observed by reverse transcription±polymerase chain reaction (RT±PCR) during differentiation of ES cells into hematopoietic lineages. In addition, the expression of mTert during this course of differentiation is very similar to the levels of telomerase activity measured by TRAP assay, thus providing further evidence that mTert is the main determinant of telomerase activity. This of course provides us with an excellent reporter system, which can be used to select, expand and study cells possessing different levels of telomerase activity both in our in vitro system and possibly in an in vivo model such as mTert-GFP transgenic mice. In this paper we also show that both the levels of mTert and telomerase activity fall similarly during the differentiation of ES cells and emergence of HSC activity thus providing us with a powerful developmental model which could be used to study the transcriptional control of murine Tert gene.
Results and discussion

Changes in mTert expression during differentiation of ES cells into hematopoietic lineages
In order to construct a reporter cassette for the murine reverse transcriptase gene we ampli®ed a 4471 bp fragment from its promoter and used this to drive the expression of GFP. This fragment which extends from 4491 to 20 bp upstream of the initiating ATG codon represents the longest mTert promoter sequence available in the databases or literature. While much work has been performed on the promoter of hTERT and its minimal core region nothing is known about the mTert promoter (Greenberg et al., 1999; Horikawa et al., 1999) . This together with the importance of c-Myc binding site for the hTERT promoter and its conservation between mouse and human sequences made us to include the whole 4.4 kb region including the prospective c-myc binding site in the mTert promoter 26 bp upstream of the initiating ATG codon in our initial reporter construct. We created mTert-GFP marked cell lines by stably transfecting this reporter into murine ES cells. The marked ES cells were maintained initially in a suitable medium in presence of LIF and then allowed to differentiate for 6 days into embryoid bodies (EBs) following the removal of LIF. The hematopoietic commitment was assessed by placing EBs at different days in the CFU-A assay. The presence or absence of hematopoietic progeny was determined by the formation of normally mixed colonies of neutrophils and macrophages. During this course of differentiation ES cells transit through an HSC phenotype, identi®cation and ampli®cation of which may provide a target for genetic and physiological modi®cations. Our previous work has indicated that the earliest time point at which HSC can be detected is 4 days (Hole et al., 1996) . In addition this hematopoietic commitment can be quantitatively enhanced or completely abrogated by the presence of low dose of dimethylsulfoxide (DMSO) or all-trans retinoic acid (RA), respectively (see Fig. 1 ). In order to observe any changes in the expression of mTert we collected samples of undifferentiated cells and EBs from each day of differentiation and performed semi quantitative RT±PCR analysis (see Fig. 2 ). As can be observed from Fig. 2 the level of mTert expression increases from day 1 to 4, a time period during which cell proliferation is enhanced, and then decreases from day 4 afterwards, a time point at which HSC activity is found and more signi®cant differentiation of EBs into hematopoietic lineages has begun. This process seems to be accelerated by one day once a morphogen that can enhance the hematopoietic commitment like DMSO is added during the ®rst 2 days of differentiation (see Figs. 1 and 2) . The presence of a morphogen such as RA which diminishes the hematopoietic commitment of EBs leads to an increase in the expression of mTert (see Figs. 1 and 2 ), suggesting that a close correlation exists between the downregulation of mTert and the differentiation process. This is not surprising since other workers have found that differentiation of the U-87MG human glioblastoma cells led to the downregulation of telomerase activity and TERT expression, but not of the hTR or hTEP1 components of the telomerase complex (Kiaris and Scally, 1999) .
Several reports have indicated that the variable expression of human TERTduring development occurs as results of two regulatory mechanisms: transcriptional control of the hTERT gene and alternative splicing of hTERT transcripts (Ulaner et al., 1998; Kilian et al., 1997) . Although our mTert RT±PCR primers¯anked the corresponding region where alternative splicing has been reported to occur in the hTERT we did not observe multiple size transcripts suggesting that alternative splicing may not occur during early mouse development.
In order to investigate whether the mTert-GFP reporter construct mimicked the changes in mTert expression during the differentiation of ES cells, we collected samples of EBs from each day of differentiation and subjected them tō uorimetric analysis (see Fig. 3 ). The measured GFP levels showed a very close resemblance to the pro®les of mTert levels obtained by PCR, suggesting that the promoter region inserted in the reporter cassette is suf®cient for mTertexpression. We also isolated populations of strongly GFP-positive cells (GFP1ve), cells with intermediate GFP intensity (GFP-Int) and GFP negative cells (GFP2ve) by subjecting them to¯ow cytometry (see Fig. 4A ) and conducted RT± PCR analysis (see Fig. 4B ). Such analysis demonstrated that cells of high GFP intensity expressed signi®cant levels of mTert while those of intermediate intensity expressed only very low levels of mTert (see Fig. 4B ). Expression of mTert could not be detected in the GFP-negative fraction. This provides us with a powerful means of separating single cells with differing levels of GFP intensity and therefore mTert expression.
The mechanism of regulation of human TERT gene expression is currently under intensive investigation. Sequence analysis has revealed that hTERT promoter contains binding sites for several transcription factors, suggesting that hTERT expression may be subject to multiple levels of control and regulated by different factors in different cellular contexts (Wick et al., 1999; Cong et al., 1999) . Several groups have shown that c-myc activates telomerase, an effect attributed to direct interaction of c-myc with the hTERT promoter (Takakura et al., 1999; Wu et al., 1999; Horikawa et al., 1999) which has been shown to posses two E boxes (CACGTG) which are known to bind factors such as Myc and its partner protein Max in the core Fig. 1 . Hematopoietic differentiation of embryonic stem cells. Embryoid bodies (EBs) were allowed to differentiate in the absence (DIF) or presence of morphogens (DMSO and RA) and hematopoietic commitment assessed by counting the proportion of embryoid bodies producing mixed colonies of neutrophils and macrophages in the CFU-A assay. DMSO (1%) or all-trans RA (10 28 M) were included in the ®rst 48 h of differentiation only. These represent the results from three independent experiments, each one being in turn the average of three replicates, therefore the most appropriate measure of variation, the standard error of the mean, is plotted on the same graph. Fig. 2 . mTert expression in differentiating EBs by RT±PCR. Total RNA was prepared and RT±PCR performed as described in Section 3. Aliquots of each reaction were equalized for the internal control actin and were run on 2% agarose gels containing ethidium bromide. promoter and in the 5 H untranslated region (Kyo et al., 2000) . Greenberg et al. have shown that alignment of the ®rst 300 bp of the hTERT and mTert promoters indicates a number of conserved regions in particular the Myc/Max binding region (E box) located at 234 in human and 232 in mouse (Greenberg et al., 1999) . The second E box of the human promoter is not conserved in mouse but the possibility still arises that c-myc may cause activation of telomerase in murine cells. Our RT±PCR analysis on sorted cells indicated that cells that expressed intermediate to high levels of mTert also expressed c-myc (see Fig. 4B ), suggesting that activation of telomerase by c-myc could be a general mechanism conserved between mice and man; further work is necessary to establish this.
Correlation of mTert expression to the telomerase activity
To measure the levels of telomerase activity, telomerase repeat ampli®cation protocol (TRAP) followed by enzymelinked immunosorbent assay (ELISA) quanti®cation of the PCR product was performed on 10 ng cell lysate from EBs collected from each day of differentiation (see Fig. 5 ). As can be observed from Fig. 5 , the telomerase activity Fig. 3 . GFP changes in differentiating mTert-GFP marked cells. EBs from mTert-GFP cells were allowed to differentiate for 6 days and¯uorimetric quantitation of GFP was performed each day as described in Section 3. increases from day 1 to 4 in the EBs incubated with differentiation medium (DIF), then decreases signi®cantly after day 4, a time point at which HSC activity is found, similarly to the expression of mTert (this process seems to be repeated in the EBs incubated with DIF and DMSO, only 1 day earlier). Contrary to the above, the telomerase activity increases from day 1 to 5 in the EBs incubated with DIF and an inhibitor of hematopoiesis such as RA, suggesting an inverse correlation between telomerase activity and differentiation of ES cells. The sudden fall of telomerase activity from day 5 to 6 in the RA series could be explained with decreasing effects of the inhibitor (RA was present only for the ®rst 48 h) or small amount of hematopoietic commitment which still occurs in this system. Although we found a relatively good correlation between mTert expression and telomerase activity in our differentiation system, we were still aware from our¯ow cytometry analysis that we were dealing with a mixed cell population which was likely to comprise cells of high, intermediate and low telomerase activity. In view of the recent ®ndings that large population of normal cells (telomerase negative) could mask the activity of tumor cells (telomerase positive) (Wu et al., 2000) , we decided to perform TRAP on 250 cells sorted by¯ow cytometry (see Fig. 6A,B) . This ®gure shows that the cells that express high levels of mTert/GFP also show a signi®cant telomerase activity (value 1.5 from ELISA quanti®cation); the cells that express intermediate levels of mTert/GFP show almost half of the telomerase activity (ELISA quantitation 0.8) while the negative cells are telomerase-negative (ELISA quantitation 0.15; this is similar to the values obtained from the control sample which contains CHAPS lysis buffer). In contrast to mTERT, levels of Tep1 mRNA show no obvious correlation with telomerase activity (see Fig. 4B ). These data suggest that mTert is likely to be the rate-determining factor for the telomerase activity. The establishment of this correlation between mTert/GFP and telomerase activity gives us a valuable means of identifying and isolating individual viable cells with differing levels of telomerase and testing them for stem cell activity by subjecting them to assays of stem cell activity such as reconstitution of the hematopoietic system of lethally irradiated mice. This reporter construct can further be used for making a mTert-GFP transgenic mice which will allow us not only to examine the spatial and temporal expression pattern of mTert throughout development of embryo and adult, but will also facilitate the isolation of telomerase-positive cells and study of their proliferative or stem cell activity.
Our study of telomerase activity during the course of differentiation of ES cells into hematopoietic progeny indicates downregulation of telomerase from day 4 (day 3 when DMSO is added) when the ®rst HSC activity is found (Hole et al., 1996) . This of course is not surprising since other workers in the ®eld have reported downregulation of telomerase activity during the differentiation of human promyelocytic leukemia HL-60 cell line as well as murine F9 teratocarcinoma cells (Bestilny et al., 1996) . What is not Fig. 5 . Telomerase activity during the differentiation of EBs from mTert-GFP cells. EBs from mTert-GFP cells were allowed to differentiate for 6 days and telomerase activity measured using the TRAP-ELISA assay as described in Section 3. clear at the present, though, is whether the observed loss of telomerase activity is due to the loss of self-renewing potential upon treatment with differentiating agents or differentiation process itself. If the latter theory is true then telomerase could be used as a marker of undifferentiated cells.
The strong correlation found in this study between the expression level of mTert and telomerase activity in our differentiation system suggests that the control of murine Tert expression occurs at the transcriptional level and, therefore, we could use this model to study the transcriptional regulation of mTert, in particular the identi®cation of proteins which may bind to the promoter. This comprises one of our future aims in this work.
Experimental procedures
Construction of mTert-GFP vector
A 4471 bp fragment of the promoter of mouse mTert gene (accession number AF 121949) was ampli®ed by PCR from the mouse genomic DNA with the following primers: mTertF 5
H -GGTACAGGATCCGAAGACAAAAGCTTC-CAGCAAACCAGTTAG-3 H and mTertR 5 H -GGTACAG-GATCCGAAGACAAGGATCCGGCCGGGATGGGCCT-CCC-3
H . The PCR fragment was digested with BamHI and HindIII, and excess primers and digestion fragments were removed using the Qiagen PCR puri®cation kit. The puri®ed PCR fragment was ligated to a promoterless GFP vector, pEGFP1 (Clontech), which was also digested with BamHI and HindIII, and transformation was carried out in Escherichia coli (INVa F H ). The same procedure was followed for transforming the control pEGFP1 vector. Plasmid DNA was prepared using the Qiagen midiprep kit and linearized using XhoI.
ES cell culture and embryoid body formation
The CGR8 cells were routinely passaged and maintained in an undifferentiated state as described by Smith (1991) in a suitable medium (GMEM (Gibco BRL) with 7.5% NaHCO 3 , non-essential amino acids, 100 mM l-glutamine and 50 mM pyruvate, 0.1 mM 2-mercaptoethanol and fetal calf serum) with leukemia inhibitory factor (LIF) which was produced by taking the conditioned medium from COS7 transfected cells with an expression construct containing the cDNA for LIF under a CMV promoter. In order to form embryoid bodies, ES cells were cultured in hanging drops (10 ml) at a concentration of 3 £ 10 4 cells/ml in the presence of LIF for 48 h in a humidi®ed 5% CO 2 atmosphere. ES cell aggregates were harvested into a Petri dish (10 3 aggregates/10 ml ES cell culture medium lacking LIF) and allowed to differentiate for up to 6 days. Medium was replaced every 2 days. Selected samples were treated with either 1% dimethylsulfoxide (DMSO; Sigma) or 10 28 M alltrans retinoic acid (RA; Sigma) for the ®rst 48 h of differentiation. About 500 EBs were removed each day from the samples treated with differentiation medium as well as from the samples treated with differentiation medium and DMSO or RA, and used for¯uorimetric quantitation of GFP and TRAP. Another 500 EBs were used for RT±PCR while remaining ones were used for the CFU-A assay.
Construction of mTert-GFP marked cells
Ten micrograms of the linearized mTert-GFP construct or control pEGFP1 was electroporated into 10 6 cells using an Electro Cell Manipulator (BioRad) and a pulse of 240 V. Cells were allowed to recover for 24 h before G418 was added to a ®nal concentration of 400 mg/ml. Seventy antibiotic-resistant colonies were picked and expanded in separate¯asks out of which ten clones were taken up for further analysis. Since they all showed similar GFP pro®les, we decided to present in this paper results from only one clone, named mTert-2, for the sake of clarity.
The CFU-A assay
The in vitro CFU-A assay was set up as described previously (Pragnell et al., 1988) . In brief, a feeder layer consisting of 0.6% agar in a modi®ed Eagle's medium (a-MEM; Gibco BRL) with conditioned medium from two cell lines (AF1-19T; a source of granulocyte macrophage colony stimulating factor, GM-CSF; and L929 a source of CSF-1) was poured into 3-cm diameter tissue culture grade dishes (1 ml per layer). Embryoid bodies were added to 0.3% agar in a-MEM and added to form an upper layer, normally 50 per dish. The dishes were incubated for 11 days at 378C in a humidi®ed atmosphere with 5% O 2 /10% CO 2 . The presence or absence of hematopoietic progeny in the differentiated EBs was determined by the formation of normally mixed colonies of neutrophils and macrophages.
RT±PCR analysis
or absence of the appropriate size PCR products. RNA controls were included to monitor genomic contamination.
Fluorimetric quantitation of GFP
Five hundred EBs from the mTert-GFP marked cells were resuspended in 100 ml of PBS and¯uorimetric quantitation of GFP in intact embryoid bodies was carried out using a Cyto¯uor Multiwell Plate reader (Perseptive Biosystems). In order to determine the background¯uorescence of EBs 500 EBs from the pEGFP1 marked cells were resuspended in PBS and subjected to the same procedure. All the measurements were carried out in triplicate. In order to determine GFP expression in terms of protein, each sample was lysed in 100 ml CHAPS lysis buffer (3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate). The cells in CHAPS lysis buffer were incubated on ice for 30 min. The insoluble cell debris was removed by centrifugation for 30 min at 12 000 £ g at 48C. The supernatant was removed into a clean tube and¯ash frozen in liquid nitrogen until required for TRAP. The amount of protein in each sample was determined using the Biorad Protein Assay. The GFP uorescence measured for each sample was normalized with respect to the amount of protein in that sample, then background¯uorescence was subtracted by performing a similar calculation on the pEGFP1 samples.
Telomeric repeat ampli®cation protocol (TRAP)
TRAP reactions were carried out using TRAPeze ELISA Telomerase Detection Kit (Oncor) following the manufacturer's instructions. Five hundred EBs, which had been used for¯uorimetric determination of GFP, were washed in PBS and directly transferred into Eppendorf tubes containing 100 ml CHAPS lysis buffer. Several protein concentrations were used in order to avoid the effect of Taq polymerase inhibitors present in the cell lysate. A ®nal concentration of 10 ng of protein from each sample was used in the PCR reaction (for each sample three PCR reactions were performed). Telomerase-speci®c products were determined by the presence of a 6 bp incremental DNA ladder on a 12% polyacrylamide gel stained with ethidium bromide. TRAP products were also quanti®ed by a colorimetric reaction using manufacturer's instruction and a Titertek Multiskan plate reader. In all assays, the CHAPS lysis buffer (2 ml) was used as a negative control for both PCR and telomerase reactions.
Flow cytometry
At day 4 of differentiation about 100 EBs were removed, washed in PBS and incubated in trypsin for 5 min. Disaggregation of EBs into cells was carried out using a 19-gauge needle. After removal of trypsin by centrifugation and washing with PBS, cells were resuspended in 500 ml of PBS containing propidium iodide (1 mg/ml) and subjected to¯ow cytometry using a Becton Dickinson FACstar and resulting in the following fractions: (ii) GFP-negative cells named GFP2ve, (iii) cells with intermediate GFP intensity named GFP-Int; (iv) strongly GFP positive cells named GFP1ve (see Fig. 4A ).
